Innovations in Prostate Cancer Treatment: Antibody-Based Radioligand Therapy and Combinations Show Promise
/0 Comments/in Review/by MaxTransdermal Estradiol: A Cost-Saving, Quality-of-Life Boost for Prostate Cancer Therapy
/0 Comments/in Review/by MaxNavigating Treatment Options after Triplet Therapy Failure in Prostate Cancer: Should a Second ARPI Be Considered?
/0 Comments/in Review/by MaxMetastasis-Directed Therapy: A Paradigm Shift in Metastatic Prostate Cancer Treatment
/0 Comments/in Review/by MaxPARP Inhibitors in Prostate Cancer: Navigating the Complexities of DNA Repair
/0 Comments/in Review/by MaxRadiotherapy in High-Burden Hormone-Sensitive Metastatic Prostate Cancer: Can It Be Useful?
/0 Comments/in Review/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC ADT AI ai in healthcare alphafold antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus personalized medicine prostate cancer PSMA radioligand therapy radiopharmaceuticals real-world data theranostics
Latest Posts
- New Phase 3 Trial Approved for Masitinib for mCRPC July 9, 2025
- Metformin and Prostate Cancer: A Review of STAMPEDE Trial from The Lancet July 9, 2025
- Newsletter 27/2025 July 6, 2025
- Korean Team Unveils Breakthrough All-in-One Cancer Nanomedicine July 5, 2025